Clinical Trials Team

Clinical Trials Expert Team

Marc Sirockman, President

Marc Sirockman brings 30 years of industry experience, unique perspectives and passion for excellence to all his client engagements. Following successful field, management and sales training positions in pharma/biotech industries, Marc has developed strategic insights in the complex touchpoint-matrix framework required to engage healthcare providers, caregivers, payers and patients. Marc was named Top 100 Pharmavoice “most inspiring leader” 2013 and 2015. Marc’s mission is to creatively engage with stakeholders to achieve an impactful single, shared voice of truth to drive performance within the complex health ecosystem.

Marc Sirockman, President

Marc Sirockman brings 30 years of industry experience, unique perspectives and passion for excellence to all his client engagements. Following successful field, management and sales training positions in pharma/biotech industries, Marc has developed strategic insights in the complex touchpoint-matrix framework required to engage healthcare providers, caregivers, payers and patients. Marc was named Top 100 Pharmavoice “most inspiring leader” 2013 and 2015. Marc mission is to creatively engage with stakeholders to achieve increased share of “signal voice of truth voice” which is impactful and drive performance within the complex health ecosystem.

David Segarnick, PhD., Chief Medical Officer

With degrees in pharmacology and neurochemistry and two decades in the industry, Dr. Segarnick has worked across most therapeutic areas and has supported the launches of blockbusters like Nexium, Prevnar 13, Tykerb, and Cervarix. Involved in every client initiative, he is an expert at building compelling narratives and bridging the communication gap between Commercial and Medical Affairs in client organizations. Dr. Segarnick was named Top 100 Pharmavoice “most inspiring leader” 2013. Dr. Segarnick is also professor, pharmacology, physiology and neuroscience at Rutgers University/New Jersey Medical School.

David Segarnick, PhD., Chief Medical Officer​

With degrees in pharmacology and neurochemistry and two decades in the industry, Dr. Segarnick has worked across most therapeutic areas and has supported the launches of blockbusters like Nexium, Prevnar 13, Tykerb, and Cervarix. Involved in every client initiative, he is an expert at building compelling narratives and bridging the communication gap between Commercial and Medical Affairs in client organizations. Dr. Segarnick was named Top 100 Pharmavoice “most inspiring leader” 2013. Dr. Segarnick is also professor, pharmacology, physiology and neuroscience at Rutgers University/New Jersey Medical School.

Dover Bull, Vice President, Strategic Accounts

Dover is a highly accomplished professional with 15+ years of experience in the pharmaceutical and medical publishing industries. Her previous responsibilities include executive leadership, strategy development, team building, sales management, marketing, key account management, and decision-making. She has a proven record of building and leading business strategy and operations. In her career, Dover has driven value from team development, custom product development, and commercial strategy. In previous roles, Dover has engineered the promotion and development of several companies. She is passionate about medical education and empowering others. Dover has a BS in Business from Delaware Valley University and a Leadership degree from University of Pennsylvania, Wharton School of Business.

Dover Bull, Vice President, Strategic Accounts

Dover is a highly accomplished professional with 15+ years of experience in the pharmaceutical and medical publishing industries. Her previous responsibilities include executive leadership, strategy development, team building, sales management, marketing, key account management, and decision-making. She has a proven record of building and leading business strategy and operations. In her career, Dover has driven value from team development, custom product development, and commercial strategy. In previous roles, Dover has engineered the promotion and development of several companies. She is passionate about medical education and empowering others. Dover has a BS in Business from Delaware Valley University and a Leadership degree from University of Pennsylvania, Wharton School of Business.

Linda Andersen, Director, Strategic Accounts – Clinical Trials

Linda is an accomplished business development manager, dimensional marketer, and solutions-minded problem solver with over 20 years of pharmaceutical industry experience. She is passionate about providing clients with creative strategies that enhance compliance, engagement, and bridge the gap in communication between key stakeholders. This methodology puts emphasis on the entire patient-caregiver experience for improved outcomes for all. Over her career, Linda has developed marketing strategies in the therapeutic areas of endocrinology, rheumatology, oncology, dermatology, neurology, as well as rare diseases. She has contributed to the development of 2 patented patient-education pieces. She holds a B.A. in Communications from Montclair State University.

Linda Andersen, Director, Strategic Accounts – Clinical Trials

Linda is an accomplished business development manager, dimensional marketer, and solutions-minded problem solver with over 20 years of pharmaceutical industry experience. She is passionate about providing clients with creative strategies that enhance compliance, engagement, and bridge the gap in communication between key stakeholders. This methodology puts emphasis on the entire patient-caregiver experience for improved outcomes for all. Over her career, Linda has developed marketing strategies in the therapeutic areas of endocrinology, rheumatology, oncology, dermatology, neurology, as well as rare diseases. She has contributed to the development of 2 patented patient-education pieces. She holds a B.A. in Communications from Montclair State University.

Sophia Maier, Director, Strategic Accounts – Clinical Trials

Sophia has a strong background in clinical nursing, as well as trial and project management. In her prior role, she served as a clinical nurse specializing in cardiac care at Abington-Jefferson Health. She has worked for several companies such as ICON Medical Imaging, assisting in identifying physicians to act as consultants and independent blinded reviewers for clinical trials. She has a B.S. in Biology from Temple University and a B.S. in Nursing from Drexel University.

Sophia Maier, Director, Strategic Accounts – Clinical Trials

Sophia has a strong background in clinical nursing, as well as trial and project management. In her prior role, she served as a clinical nurse specializing in cardiac care at Abington-Jefferson Health. She has worked for several companies such as ICON Medical Imaging, assisting in identifying physicians to act as consultants and independent blinded reviewers for clinical trials. She has a B.S. in Biology from Temple University and a B.S. in Nursing from Drexel University.

Why MedEvoke for Clinical Trials

© 2018 MedEvoke. All rights reserved

MedEvoke holds certifications from Women’s Business Enterprise National Council (WBENC), National Minority Supplier Development Council Inc (NMSDC), Small Business Administration (SBA), and Diversity Alliance for Science (DA4S).

Contact us

Phone: 908.638.5885

65 Main St.

High Bridge, NJ 08829